Franzmeier, Nicolai http://orcid.org/0000-0001-9736-2283
Ren, Jinyi
Damm, Alexander
Monté-Rubio, Gemma
Boada, Mercè
Ruiz, Agustín
Ramirez, Alfredo http://orcid.org/0000-0003-4991-763X
Jessen, Frank
Düzel, Emrah
Rodríguez Gómez, Octavio
Benzinger, Tammie
Goate, Alison http://orcid.org/0000-0002-0576-2472
Karch, Celeste M. http://orcid.org/0000-0002-6854-5547
Fagan, Anne M.
McDade, Eric
Buerger, Katharina
Levin, Johannes
Duering, Marco
Dichgans, Martin
Suárez-Calvet, Marc
Haass, Christian http://orcid.org/0000-0002-4869-1627
Gordon, Brian A. http://orcid.org/0000-0003-2109-2955
Lim, Yen Ying
Masters, Colin L.
Janowitz, Daniel
Catak, Cihan
Wolfsgruber, Steffen
Wagner, Michael
Milz, Esther
Moreno-Grau, Sonia
Teipel, Stefan
Grothe, Michel J http://orcid.org/0000-0003-2600-9022
Kilimann, Ingo
Rossor, Martin
Fox, Nick
Laske, Christoph
Chhatwal, Jasmeer
Falkai, Peter
Perneczky, Robert http://orcid.org/0000-0003-1981-7435
Lee, Jae-Hong
Spottke, Annika
Boecker, Henning
Brosseron, Frederic
Fliessbach, Klaus
Heneka, Michael T. http://orcid.org/0000-0003-4996-1630
Nestor, Peter
Peters, Oliver
Fuentes, Manuel
Menne, Felix
Priller, Josef
Spruth, Eike J.
Franke, Christiana
Schneider, Anja
Westerteicher, Christine
Speck, Oliver
Wiltfang, Jens http://orcid.org/0000-0003-1492-5330
Bartels, Claudia
Araque Caballero, Miguel Ángel
Metzger, Coraline
Bittner, Daniel
Salloway, Stephen http://orcid.org/0000-0002-2631-0942
Danek, Adrian http://orcid.org/0000-0001-8857-5383
Hassenstab, Jason
Yakushev, Igor
Schofield, Peter R. http://orcid.org/0000-0003-2967-9662
Morris, John C.
Bateman, Randall J.
Ewers, Michael
Funding for this research was provided by:
The FACEHBI study is supported by Grifols®, Piramal®, Araclon Biotech®, Laboratorios Echevarne S.A. and Fundació ACE, Institut Català de Neurociències Aplicades.
Article History
Received: 19 October 2018
Revised: 19 January 2019
Accepted: 14 February 2019
First Online: 21 March 2019
Compliance with ethical standards
:
: A.M.F. has received research funding from Biogen, Fujirebio, and Roche Diagnostics. She is a member of the scientific advisory boards for Roche, Genentech, and AbbVie and also consults for Araclon/Griffols and DiamiR.: Y.Y.L. has served as a scientific consultant to Biogen and Lundbeck; M.B. who has consulted or advisory board for Araclon, Grifols, Lilly, Nutricia, Roche and Servier. She received fees for lectures and funds for research from Araclon, Grifols, Nutricia, Roche and Servier. She has not received personal compensations from these organizations. A. Ruiz has consulted for Grifols and Landsteiner Genmed. He received funds for research and/or reimbursement of expenses for congresses attendance from Araclon, and Grifols. He has not received personal compensations from these organizations: T.B., Investigator, initiated research funding sponsored by Avid Radiopharmaceuticals (a wholly owned subsidiary of Eli Lilly) and Foundation for the NIH. Clinical trials sponsored by Avid Radiopharmaceuticals, Eli Lilly, Roche, Jaansen, Biogen, and NIH. Travel sponsored by the American Society for Neuroradiology, Alzheimer’s Association International Convention, NIH. The remaining authors declare that they have no conflict of interest.